Moraxella catarrhalis outer membrane protein CD elicits antibodies that inhibit CD binding to human mucin and enhance pulmonary clearance of M. catarrhalis in a mouse model

Infection and Immunity

Volumn 75, Issue 6, 2007, Pages 2818-2825

  Liu, Dai Fang ^a   McMichael, John C ^a,b   Baker, Steven M ^a  

^a WYETH RESEARCH   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL VACCINE; MUCIN; OUTER MEMBRANE PROTEIN; PROTEIN CD; RECOMBINANT PROTEIN; RECOMBINANT PROTEIN CD; UNCLASSIFIED DRUG; UREA;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BINDING AFFINITY; CELL INCLUSION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; FEMALE; HUMAN; ION EXCHANGE CHROMATOGRAPHY; MOLECULAR CLONING; MORAXELLA CATARRHALIS; MORAXELLACEAE INFECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RESPIRATORY TRACT INFECTION;

ADHESINS, BACTERIAL; ANIMALS; ANTIBODIES, BACTERIAL; DISEASE MODELS, ANIMAL; HUMANS; LUNG; MICE; MICE, KNOCKOUT; MORAXELLA (BRANHAMELLA) CATARRHALIS; MUCINS; RECOMBINANT FUSION PROTEINS;

EID: 34249874582     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.00074-07     Document Type: Article

References (45)

1. Barreiro, B., L. Estaban, E. Prats, E. Verdaguer, J. Dorca, and F. Manresa. 1992. Branhamella catarrhalis respiratory infections. Eur. Respir. J. 5:675-679.
2. Berk, S. L., and J. H. Kalbfleisch. 1996. Antibiotic susceptibility patterns of community-acquired respiratory isolates of Moraxella catarrhalis in Western Europe and in the USA. J. Antimicrob. Chemother. 38:85-96.
3. Berner, R., R. F. Schumacher, M. Brandis, and J. Forster. 1996. Colonization and infection with Moraxella catarrhalis in childhood. Eur. J. Clin. Microbiol. Infect. Dis. 15:506-509.
4. Bernstein, J. M., and M. Reddy. 2000. Bacteria-mucin interaction in the upper aerodigestive tract shows striking heterogeneity: implications in otitis media, rhinosinusitis, and pneumonia. Otolaryngol. Head Neck Surg. 122: 514-520.
5. Black, A. J., and T. S. Wilson. 1988. Immunoglobulin G (IgG) serological response to Branhamella catarrhalis in patients with acute bronchopulmonary infections. J. Clin. Pathol. 41:329-333.
6. Boyle, F. M., P. R. Georghiou, M. H. Tilse, and J. G. McCormack. 1991. Branhamella (Moraxella) catarrhalis: pathogenic significance in respiratory infections. Med. J. Aust. 154:592-596.
7. Chen, D., J. C. McMichael, K. R. VanDerMeid, D. Hahn, T. Mininni, J. Cowell, and J. Eldridge. 1996. Evaluation of purified UspA from Moraxella catarrhalis as a vaccine in a murine model after active immunization. Infect. Immun. 64:1900-1905.
8. Doern, G. V., A. B. Brueggemann, G. Pierce, T. Hogan, H. P. Holley, and A. Rauch. 1996. Prevalence of antimicrobial resistance among 723 outpatient clinical isolates of Moraxella catarrhalis in the United States in 1994 and 1995: results of a 30-center national surveillance study. Antimicrob. Agents Chemother. 40:2884-2886.
9. Eskola, J., and T. Kilpi. 2000. Potential of bacterial vaccines in the prevention of acute otitis media. Pediatr. Infect. Dis. J. 19:S72-S78.
10. Forsgren, A. M., M. Brant, M. Karamehmedovic, and K. Riesbeck. 2003. The immunoglobulin D-binding protein MID from Moraxella catarrhalis is also an adhesin. Infect. Immun. 71:3302-3309.
11. Harabuchi, Y., H. Murakata, M. Goh, H. Kodama, A. Kataura, H. Faden, and T. Murphy. 1998. Serum antibodies specific to CD outer membrane protein of Moraxella catarrhalis, P6 outer membrane protein of non-typeable Haemophilus influenzae and capsular polysaccharides of Streptococcus pneumoniae in children with otitis media with effusion. Acta Otolaryngol. (Stockholm) 118:826-832.
12. Helminen, M. E., I. Maciver, J. L. Latimer, L. D. Cope, G. H. McCracken, and E. J. Hansen. 1993. A major outer membrane protein of Moraxella catarrhalis is a target for antibodies that enhance pulmonary clearance of the pathogen in an animal model. Infect. Immun. 61:2003-2010.
13. Helminen, M. E., I. Maciver, J. L. Latimer, J. Klesney-Tait, L. D. Cope, M. Paris, G. H. McCracken, and E. J. Hansen. 1994. A large, antigenically conserved protein on the surface of Moraxella catarrhalis is a target for protective antibodies. J. Infect. Dis. 170:867-872.
14. Hill, D. J., and M. Virji. 2003. A novel cell-binding mechanism of Moraxella catarrhalis ubiquitous surface protein UspA: specific targeting of the N-domain of carcinoembryonic antigen-related cell adhesion molecules by UspAl. Mol. Microbiol. 48:117-129.
15. Holm, M. M., S. L. Vanlerberg, I. M. Foley, D. D. Sledjeski, and E. R. Lafontaine. 2004. The Moraxella catarrhalis porin-like outer membrane protein CD is an adhesin for human lung cells. Infect. Immun. 72:1906-1913.
16. Holm, M. M., S. L. Vanlerberg, D. D. Sledjeski, and E. R. Lafontaine. 2003. The Hag protein of Moraxella catarrhalis strain 035E is associated with adherence to human lung and middle ear cells. Infect. Immun. 71:4977-1984.
17. Hsiao, C. B., S. Sethi, and T. F. Murphy. 1995. Outer membrane protein CD of Branhamella catarrhalis: sequence conservation in strains recovered from the human respiratory tract. Microb. Pathog. 19:215-225.
18. Hu, W.-G., J. Berry, J. Chen, and X.-X. Gu. 2004. Exploration of Moraxella catarrhalis outer membrane proteins, CD and UspA, as new carriers for lipooligosaccharide-based conjugates. FEMS Immunol. Med. Microbiol. 41: 109-115.
19. Jacobs, M. R., R. Dagan, P. C. Appelbaum, and D. J. Burch. 1998. Prevalence of antimicrobial-resistant pathogens in middle ear fluid: multinational study of 917 children with acute otitis media. Antimicrob. Agents Chemother. 42:589-595.
20. Karalus, R., and A. Campagnari. 2000. Moraxella catarrhalis: a review of an important mucosal pathogen. Microbes Infect. 2:547-559.
21. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
22. Lafontaine, E. R., L. D. Cope, C. Aebi, J. L. Latimer, G. H. McCracken, and E. J. Hansen. 2000. The UspA1 protein and a second type of UspA2 protein mediate adherence of Moraxella catarrhalis to human epithelial cells in vitro. J. Bacteriol. 182:1364-1373.
23. Liu, D.-F., X. Xie, M. G. Mastri, M. Fortuna-Nevin, C. Colocillo, L. Fletcher, D. A. Dilts, J. C. McMichael, and S. M. Baker. 2006. Polymorphism of the major surface epitope of the CopB outer membrane protein of Moraxella catarrhalis. FEMS Immunol. Med. Microbiol. 47:343-350.
24. Maciver, I., M. Unhanand, G. H. McCracken, and E. J. Hansen. 1993. Effect of immunization on pulmonary clearance of Moraxella catarrhalis in an animal model. J. Infect. Dis. 168:469-172.
25. Mathers, K., M. Leinenen, and D. Goldblatt. 1999. Antibody response to outer membrane proteins of Moraxella catarrhalis in children with otitis media. Pediatr. Infect. Dis. J. 18:982-988.
26. McMichael, J. 2000. Vaccines for Moraxella catarrhalis. Vaccine 19:S101-S107.
27. Meier, P. S., S. Freiburghaus, A. Martin, N. Heiniger, R. Troller, and C. Aebi. 2003. Mucosal immune response to specific outer membrane proteins of Moraxella catarrhalis in young children. Pediatr. Infect. Dis. J. 22:256-262.
28. Meier, P. S., N. Heiniger, R. Troller, and C. Aebi. 2003. Salivary antibodies directed against outer membrane proteins of Moraxella catarrhalis in healthy adults. Infect. Immun. 71:6793-6798.
29. Murphy, T. F. 1998. Branhamella catarrhalis: epidemiological and clinical aspects of a human respiratory tract pathogen. Thorax 53:124-128.
30. Murphy, T. F., A. L. Brauer, C. Aebi, and S. Sethi. 2005. Identification of surface antigen of Moraxella catarrhalis as targets of human serum antibody responses in chronic obstructive pulmonary disease. Infect. Immun. 73:3471-3478.
31. Murphy, T. F., C. Kirkham, E. DeNardin, and S. Sethi. 1999. Analysis of antigenic structure and human immune response to outer membrane protein CD of Moraxella catarrhalis. Infect. Immun. 67:4578-4585.
32. Murphy, T. F., C. Kirkham, and A. J. Lesse. 1993. The major heat-modifiable outer membrane protein CD is highly conserved among strains of BranhameUa catarrhalis. Mol Microbiol. 10:87-97.
33. Murphy, T. F., C. Kirkham, D.-F. Liu, and S. Sethi. 2003. Human immune response to outer membrane protein CD of Moraxella catarrhalis in adults with chronic obstructive pulmonary disease. Infect. Immun. 71:1288-1294.
34. Murphy, T. F., J. M. Kyd, A. John, C. Kirkham, and A. W. Cripps. 1998. Enhancement of pulmonary clearance of Moraxella (Branhamella) catarrhalis following immunization with outer membrane protein CD in a mouse model. J. Infect. Dis. 178:1667-1675.
35. Murphy, T. F., and S. Sethi. 1992. Bacterial infection in chronic obstructive pulmonary disease. Am. Rev. Respir. Dis. 146:1067-1083.
36. Nordstrom, T., A. M. Forsgren, and K. Riesbeck. 2002. The immunoglobulin D-binding part of the outer membrane protein MID from Moraxella catarrhalis comprises 238 amino acids and a tetrameric structure. J. Biol. Chem. 277:34692-34699.
37. Pearson, M. M., E. R. Lafontaine, N. J. Wagner, J. W. St. Geme III, and E. J. Hansen. 2002. A hag mutant of Moraxella catarrhalis strain 035E is deficient in hemagglutination, autoagglutination, and immunoglobulin D-binding activities. Infect. Immun. 70:4523-1533.
38. Peterson, G. L. 1977. A simplification of the protein assay method of Lowry et al which is more generally applicable. Anal. Biochem. 83:346-356.
39. Reddy, M. S., T. F. Murphy, H. S. Faden, and J. M. Bernstein. 1997. Middle ear mucin glycoprotein: purification and interaction with nontypeable Haemophilus influenzae and Moraxella catarrhalis. Otolaryngol. Head Neck Surg. 116:175-180.
40. Ruuskanen, O., and T. Heikkinen. 1994. Otitis media: etiology and diagnosis. Pediatr. Infect. Dis. J. 13:S23-S26.
41. Sarwar, J., A. A. Campagnari, C. Kirkham, and T. F. Murphy. 1992. Characterization of an antigenically conserved heat-modifiable major outer membrane protein of Branhamella catarrhalis. Infect. Immun. 60:804-809.
42. Timpe, J. M., M. M. Holm, S. L. Vanlerberg, V. Basrur, and E. R. Lafontaine. 2003. Identification of a Moraxella catarrhalis outer membrane protein exhibiting both adhesin and lipolytic activities. Infect. Immun. 71:4341-1350.
43. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from acrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76:4350-4354.
44. Verduin, C. M., C. Hol, A. Fleer, H. van Dijk, and A. van Belkum. 2002. Moraxella catarrhalis: from emerging to established pathogen. Clin. Microbiol. Rev. 15:125-144.
45. Yang, Y. P., L. E. Myers, U. McGuinness, P. Chong, Y. Kwok, M. H. Klein, and R. E. Harkness. 1997. The major outer membrane protein, CD, extracted from Moraxella (Branhamella) catarrhalis is a potential vaccine antigen that induces bactericidal antibodies. FEMS Immunol. Med. Microbiol. 17:187-199.